TrialJournal of acquired immune deficiency syndromes (1999)2017

Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults.

François Raffi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.